← Back to directory

Astra M. Liepa

Researcher Next ID · RN-025857

Researcher · Medicine

Eli Lilly (United States)

Indianapolis, Latvia

Not currently recruitingFunding unknown
Works count
129
Citation count
5,511
H-index
32
i10-index
48

Research interests

Medicine
Economics, Econometrics and Finance
Gastric Cancer Management and Outcomes
Lung Cancer Treatments and Mutations
Esophageal Cancer Research and Treatment
Colorectal Cancer Treatments and Studies
Economic and Financial Impacts of Cancer

Publications

  • Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

    The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)32365-6

  • Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

    The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(13)61719-5

  • Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

    Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.23.2595

  • What Is Sufficient Evidence for the Reliability and Validity of Patient-Reported Outcome Measures?

    Value in Health · 2007 · https://doi.org/10.1111/j.1524-4733.2007.00272.x

  • Health-Related Quality-of-Life Parameters as Independent Prognostic Factors in Advanced or Metastatic Bladder Cancer

    Journal of Clinical Oncology · 2003 · 10.1200/jco.2003.04.166

Current projects

    No projects listed.